Zydus Lifesciences Limited
ZYDUSLIFE · ISIN: INE010B01027
Constituent of NIFTY 100 TRI (0.20%), NIFTY 500 TRI (0.14%), NIFTY LMC 250 TRI (0.10%), NIFTY MC 150 TRI (0.72%)
Earnings (TTM)
CHART
Zydus Lifesciences Limited - revenue & profit (TTM)
Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.
22.79%
EBITDA Margin (TTM)
44.87
EPS (TTM)
25.45%
EPS Growth (5Y)
13.16%
EPS Growth (10Y)
Technicals
50.98
RSI (14)
1136.78
SMA (50)
993.34
SMA (200)
16.23
ADX (14)
1205
52-Week High
835.5
52-Week Low
15%
1Y Return
175.2031
Avg Traded Value (20D, ₹Cr)
As of 2026-09-08.
Shareholding Pattern
CHART
Shareholding by category
As of 2026-06-30.
F&O Sentiment
Nearest expiry: 2026-09-29 · As of 2026-09-07.
0.5435
PCR (OI)
0.3718
PCR (Volume)
1150
Max Pain Strike
Corporate Actions
| Ex-Date | Type | Ratio | Details |
|---|---|---|---|
| 2015-10-06 | SPLIT | 0.200000 | FACE VALUE SPLIT (SUB-DIVISION) - FROM RS 5/- PER SHARE TO RE 1/- PER SHARE |
| 2010-04-05 | BONUS | 0.666667 | BONUS 1: 2 |
Recent Deals
No recent block/bulk/short-sell deals on record for this stock.
Stock data · Not financial advice · Past performance does not indicate future returns